News | March 20, 2026
Epigenica expands into Japan via PrimeTech partnership
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The trial will enroll up to 42 patients in Finland across four cohorts
The trial met its primary endpoint, showing statistically significant improvements in Myasthenia Impairment Index (MGII) Patient-Reported Outcome (PRO) ocular scores at Week 4
If approved, TEV-'749 could help address a significant unmet need in available schizophrenia treatment options by addressing the lack of viable long-acting olanzapine formulations
A final tranche of €12 million will follow, contingent on positive pivotal study results, with the share price calculated according to an agreed formula
Alto met its enrollment goal with 83 patients across 13 US clinical sites
The new OMR facility, located in Chennai’s medical hub, is close to leading hospitals and offers excellent road and air connectivity
HCG clinicians contributing to one of the largest bodies of oncology research from India
Hologic has been at the forefront of cervical cancer screening for decades
Subscribe To Our Newsletter & Stay Updated
